Karin Hardt
Impact in
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Epidemiology top 0.5%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
Papers in
- Epidemiology 25
- Cervical Cancer and HPV Research 17
- Hepatitis B Virus Studies 13
-
- Bacterial Infections and Vaccines 7
- Co-authors
- Gary O. Dubin (8 shared papers)Dominique Descamps (8 shared papers)Bart Spiessens (3 shared papers)Thomas Breuer (2 shared papers)Patricia Izurieta (2 shared papers)Thomas Verstraeten (2 shared papers)Pierre Van Damme (4 shared papers)Marie‐Pierre David (2 shared papers)
- Journals
- Vaccine (13 papers)Human Vaccines & Immunotherapeutics (5 papers)The Pediatric Infectious Disease Journal (3 papers)Journal of Adolescent Health (2 papers)Human Vaccines (2 papers)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
Karin Hardt
56 papers receiving 6.2k citations
Karin Hardt's Hit Papers
Peers
Comparison fields: 5 of 127
- Infectious Diseases 2.1k
- Epidemiology 3.2k
- Health 694
- Microbiology 299
- Hepatology 296
Countries citing papers authored by Karin Hardt
This map shows the geographic impact of Karin Hardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Hardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Hardt more than expected).
Fields of papers citing papers by Karin Hardt
This network shows the impact of papers produced by Karin Hardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Hardt. The network helps show where Karin Hardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Karin Hardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 Hit paper breakdown → | 2021 | 1845 |
| 2 | Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women Hit paper breakdown → | 2009 | 1375 |
| 3 | 2011 | 423 | |
| 4 | 2007 | 210 | |
| 5 | 2005 | 179 | |
| 6 | Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S Hit paper breakdown → | 2022 | 178 |
| 7 | 2011 | 168 | |
| 8 | 2009 | 158 | |
| 9 | 2016 | 158 | |
| 10 | 2014 | 151 | |
| 11 | 2008 | 133 | |
| 12 | 2004 | 133 | |
| 13 | 2008 | 131 | |
| 14 | 2009 | 122 | |
| 15 | 2011 | 118 | |
| 16 | 2015 | 100 | |
| 17 | 2016 | 96 | |
| 18 | 2022 | 65 | |
| 19 | 2013 | 58 | |
| 20 | 2014 | 56 |
About Karin Hardt
Karin Hardt is a scholar working on Epidemiology, Microbiology, Infectious Diseases, Hepatology and Health, having authored 57 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (13 papers), Bacterial Infections and Vaccines (7 papers), Viral gastroenteritis research and epidemiology (6 papers), Hepatitis Viruses Studies and Epidemiology (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers), Genital Health and Disease (4 papers) and Viral Infections and Immunology Research (4 papers). The work is most often cited by research in Infectious Diseases (2.1k citations), Epidemiology (3.2k citations), Health (694 citations), Microbiology (299 citations) and Hepatology (296 citations). Karin Hardt has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Gary O. Dubin, Dominique Descamps, Bart Spiessens, Thomas Breuer, Patricia Izurieta, Thomas Verstraeten, Pierre Van Damme, Marie‐Pierre David, Koen Van Herck and Priya Diana Crasta. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, The Pediatric Infectious Disease Journal, Journal of Adolescent Health and Human Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.